Bile Duct Cancer Causes, Risk Factors, and Prevention
Learn about the risk factors for bile duct cancer and what you might be able to do to help lower your risk.
What causes bile duct cancer?
We don¡¯t know the exact cause of most bile duct cancers, but we do know some of the risk factors that make a person more likely to develop these cancers.
There seems to be a link between bile duct cancer and things that irritate and inflame the bile ducts. These may be bile duct stones, infection with a parasite, or something else.
Gene changes and bile duct cancer
Bile duct cancer can be linked to changes in certain genes. Here's what we know about how those changes happen.
Oncogenes and tumor suppressor genes
Scientists are starting to understand how inflammation might lead to certain changes in the DNA. These changes can cause cells to grow out of control and form cancers. DNA is the chemical in every cell that makes up genes. Genes are the instructions for how cells function.
- Genes that help cells grow and divide into new cells are called oncogenes.
- Genes that slow down cell division or cause cells to die at the right time are called tumor suppressor genes.
Cancers can be caused by DNA changes (mutations) that turn on oncogenes or turn off tumor suppressor genes. Changes in many different genes are usually needed for a cell to become cancer.
Acquired gene changes
Gene mutations related to bile duct cancers are usually acquired during life rather than inherited. Some of the gene changes that lead to bile duct cancer might be caused by inflammation in the bile ducts, such as from primary sclerosing cholangitis or a liver fluke infection. But often the cause is not known. Many gene changes might just be random events that sometimes happen inside a cell, without having an outside cause.
Some acquired gene changes are found more often in bile duct cancers. These include changes in:
- TP53 and KRAS
- IDH1
- FGFR2 (often a fusion, where part of the FGFR2 gene joins with part of another gene)
- HER2 (also called ERBB2)
- BRAF V600E
Less often, bile duct cancers might have fusions in the NTRK, RET, or NRG1 genes, or have certain other biomarker features, such as a high level of microsatellite instability (MSI-H) or a high tumor mutational burden (TMB-H).
Learn more about Biomarker and Tumor Marker Testing.
Which changes are most common depends partly on where the cancer starts: inside the liver (intrahepatic) or outside it (extrahepatic). Some of these changes can be targeted with certain drugs, which is why doctors often test bile duct cancers for gene changes.
Inherited gene changes
We usually look like our parents because they are the source of our DNA. But DNA affects more than how we look. Some people inherit DNA changes (mutations) from their parents that greatly increase their risk for certain cancers.
Genetic disorders linked with an increased risk of bile duct cancer include:
- Lynch syndrome
- BAP1 tumor predisposition syndrome
- Cystic fibrosis
- Multiple biliary papillomatosis
Bile duct cancer risk factors
A risk factor is anything that affects your chance of getting a disease like cancer. Different cancers have different risk factors. Some risk factors, like smoking, can be changed. Others, like your age or family history, can¡¯t be changed.
Scientists have found a few risk factors that make a person more likely to develop bile duct cancer.
But having a risk factor, or even many risk factors, does not mean that a person will get the disease. And many people who get the disease have few or no known risk factors
Knowing about the risk factors for bile duct cancer can help you find out if there are things you can do that might help lower your risk.
Certain diseases of the liver or bile ducts
Certain conditions of the liver or bile ducts have been found to either cause bile duct cancer or to increase the risk of developing it.
Primary sclerosing cholangitis (PSC) causes inflammation in the bile ducts (cholangitis). Over time, this leads to scarring called sclerosis. Doctors usually don¡¯t know what causes the inflammation. Many people with PSC also have inflammation of the large intestine, called ulcerative colitis.
Bile duct stones (hepatolithiasis) are a lot like gallstones, but much smaller. They can also cause inflammation that increases the risk of bile duct cancer.
Choledochal cyst disease is a rare condition that some people are born with. Choledochal means having to do with the common bile duct.
This disease causes bile-filled sacs along the bile ducts. If this is not treated, the bile sitting in these sacs causes inflammation of the duct walls. The cells of the duct wall may develop precancerous changes. Over time, these changes can progress to bile duct cancer.
Liver fluke infections can happen when you eat raw or undercooked fish that is infected with these tiny parasitic worms. In humans, liver flukes live in the bile ducts and can cause bile duct cancer. There are several types of liver flukes. The ones most closely related to bile duct cancer risk are Clonorchis sinensis and Opisthorchis viverrini.
Liver fluke infection is rare in the US. It is more common in some Southeast Asian countries. It can also affect people who travel to Asia.
Normally, the bile duct and the pancreatic duct join inside the wall of the small intestine. There, a ring of muscle (a sphincter) controls the flow of bile and digestive juices. Some people are born with these ducts joining outside the wall of the intestine instead. This is called pancreaticobiliary maljunction.
Because the muscle can't control the flow at that spot, digestive juices from the pancreas can flow back (reflux) into the bile ducts. Over time, this can irritate and damage the lining of the bile ducts and gallbladder. People with this condition have a higher risk of bile duct cancer and gallbladder cancer. It's often found along with choledochal cysts.
Cirrhosis is damage to the liver caused by scar tissue. Cirrhosis can be caused by substances like alcohol. It can also be caused by diseases, such as hepatitis or nonalcoholic fatty liver disease. Studies have found cirrhosis increases the risk of bile duct cancer.
Infection with hepatitis B virus or hepatitis C virus appears to be linked to increased risk for bile duct cancers. This may be in part because long-term infections with these viruses can also lead to cirrhosis.
Inherited and personal risk factors
Inflammatory bowel disease includes ulcerative colitis and Crohn¡¯s disease. People with these diseases have an increased risk of bile duct cancer. The highest risk is in people who also have primary sclerosing cholangitis (PSC). However, the risk is still slightly higher in people with inflammatory bowel disease alone.
Older people are more likely than younger people to get bile duct cancer. Most people diagnosed with bile duct cancer are in their 60s or 70s.
In the US, the risk of bile duct cancer is highest among Hispanic ÌÇÐÄTV¹ÙÍøs. Worldwide, bile duct cancer is much more common in Southeast Asia and China. This is largely because of the high rate of infection with liver flukes in these areas.
Lifestyle, health, and exposure factors
Having excess body weight or obesity can increase the risk of cancers of the gallbladder and bile ducts. This could be because obesity increases the risk of gallstones and bile duct stones, as well as the risk of non-alcoholic fatty liver disease. But there may be other ways that excess body weight can lead to bile duct cancers, such as changes in certain hormones.
People with diabetes type 1 or type 2 have been found to have a higher risk of bile duct cancer. It¡¯s unclear whether this is because of high levels of blood sugar or because of other diabetes-associated issues such as excess body weight or high cholesterol.
People who drink alcohol are more likely to get intrahepatic bile duct cancer. The risk is higher for those who have liver problems from drinking alcohol.
A radioactive substance called Thorotrast (thorium dioxide) was used as a contrast agent for x-rays until the 1950s. Then its production and use was banned. It was found to increase the risk for bile duct cancer, as well as other types of liver cancer.
Other possible risk factors
Studies have found other factors may also increase the risk of bile duct cancer. But for these factors, the link to bile duct cancer risk is not as clear.
Other possible risk factors include:
- Smoking
- Chronic pancreatitis (long-term inflammation of the pancreas)
- Infection with HIV (the virus that causes AIDS)
- Exposure to asbestos
- Exposure to radon or other radioactive chemicals
- Exposure to dioxin, nitrosamines, or polychlorinated biphenyls (PCBs) People who work in rubber plants and automotive industries may be exposed more often to these chemicals.
Can bile duct cancer be prevented?
There's no known way to prevent most bile duct cancers in the US. Many of the known risk factors for bile duct cancer, such as age, ethnicity, and differences in how the bile ducts formed before birth, can¡¯t be changed. But there are things you can do that might help lower your risk.
Diet and physical activity
Getting to and staying at a healthy weight is one important way you might be able to reduce your risk of bile duct cancer, as well as many other types of cancer.
The ÌÇÐÄTV¹ÙÍø Cancer Society recommends that people try to stay at a healthy weight, keep physically active, and follow a healthy eating pattern. This includes eating plenty of fruits, vegetables, and whole grains, and limiting or avoiding red and processed meats, sugary drinks, and highly processed foods.
Other ways to reduce your risk
Other ways you might be able to reduce your risk of bile duct cancer include:
- Get vaccinated against the hepatitis B virus (HBV) to prevent infection with the virus and the cirrhosis it can cause.
- Prevent infections by taking precautions to avoid blood-borne or sexually transmitted infections like HBV, hepatitis C, and other viruses that can cause cirrhosis.
- Treat hepatitis infections (such as B and C) to help prevent cirrhosis.
- Avoid or limit alcohol. It¡¯s best not to drink alcohol. If you do drink, have no more than 1 drink per day for women or 2 drinks per day for men.
- Quit (or don¡¯t start) smoking. Learn more about how to quit using tobacco.
- Avoid exposure to chemicals.
- Take precautions when you travel. If you travel to parts of the world where liver flukes are common, drink only purified water and eat only foods that have been thoroughly cooked.
- Written by
- References
Developed by the ÌÇÐÄTV¹ÙÍø Cancer Society medical and editorial content team with medical review and contribution by the ÌÇÐÄTV¹ÙÍø Society of Clinical Oncology (ASCO).
Banales JM, Rodrigues PM, Aff¨° S, et al; International CCA Consensus Consortium. Cholangiocarcinoma 2026: status quo, unmet needs and priorities. Nat Rev Gastroenterol Hepatol. 2026;23(1):65-96.
Ellington TD, Momin B, Wilson RJ, Henley SJ, Wu M, Ryerson AB. Incidence and mortality of cancers of the biliary tract, gallbladder, and liver by sex, age, race/ethnicity, and stage at diagnosis: United States, 2013 to 2017. Cancer Epidemiol Biomarkers Prev. 2021;30(9):1607-1614.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma. J Hepatol. 2025;83(1):211-238.
Gujarathi R, Peshin S, Zhang X, Bachini M, Meeks MN, Shroff RT, Pillai A. Intrahepatic cholangiocarcinoma: insights on molecular testing, targeted therapies, and future directions from a multidisciplinary panel. Hepatol Commun. 2025;9(7):e0743.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers. Version 1.2026. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/btc.pdf on September 9, 2026.
Petrick JL, Campbell PT, Koshiol J, et al. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Br J Cancer. 2018;118(7):1005-1012.
Petrick JL, Yang B, Altekruse SF, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare. PLoS One. 2017:12(10).
Walpole S, Pritchard AL, Cebulla CM, et al. Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide. J Natl Cancer Inst. 2018;110(12):1328-1341.
Yamada A, Komaki Y, Komaki F, Micic D, Zullow S, Sakuraba A. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis. Lancet Oncol. 2018 Jun;19(6):758-767. doi: 10.1016/S1470-2045(18)30188-8. Epub 2018 Apr 26.
Yeung YP, AhChong K, Chung CK, Chun AY. Biliary papillomatosis: report of seven cases and review of English literature. J Hepatobiliary Pancreat Surg. 2003;10(5):390-5.
Last Revised: October 27, 2026
ÌÇÐÄTV¹ÙÍø Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
ÌÇÐÄTV¹ÙÍø Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the ÌÇÐÄTV¹ÙÍø Cancer Society.
